epigenetic therapy
Showing 1 - 25 of >10,000
MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)
Recruiting
- Myelodysplastic Syndromes
- MDS/MPN Crossover Syndromes
-
Cleveland, OhioCleveland Medical Center, University Hospitals Seidman Cancer Ce
Aug 10, 2022
Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)
Not yet recruiting
- Polycystic Ovary Syndrome
- laparoscopy / laparotomy
- NO INTERVENTION
-
Hyderabad, Telangana, IndiaDr. Shraddha Ramchandani
Oct 25, 2023
Aging Trial in Florham Park (Hyperbaric Oxygen Therapy)
Recruiting
- Aging
- Hyperbaric Oxygen Therapy
-
Florham Park, New JerseyNew Jersey HBOT
Mar 16, 2022
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
- Defactinib
-
Sydney, New South Wales, Australia
- +3 more
Jan 12, 2023
Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)
Recruiting
- Liver Cirrhosis
- +2 more
- Prolonged-Release Pirfenidone
-
Guadalajara, Jalisco, Mexico
- +1 more
Sep 13, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- Prognostic Stage IV Breast Cancer AJCC v8
- Pembrolizumab
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 5, 2023
Genetic Aspects of Vaginal Aging
Recruiting
- Genitourinary Agents
-
Warsaw, PolandCentrum Medyczne "ŻELAZNA"
Apr 7, 2022
Cortisol Excess, Stress, Psychological, Anxiety Trial in Bogotá (Immersion therapy in nature - Vitamin N)
Not yet recruiting
- Cortisol Excess
- +5 more
- Immersion therapy in nature - Vitamin N
-
Bogotá, ColombiaInstituto Nacional de Salud
Mar 29, 2022
Acute Myeloid Leukemia Trial in Heidelberg (Bortezomib, Gemtuzumab Ozogamicin)
Recruiting
- Acute Myeloid Leukemia
- Bortezomib
- Gemtuzumab Ozogamicin
-
Heidelberg, Baden-Württemberg, GermanyUniversity Hospital Heidelberg, Internal Medicine V
May 25, 2020
Longitudinal Metabolomic and Epigenetic Profiling of Bodyfluids
Active, not recruiting
- Adult Brain Tumor
- +2 more
- laboratory biomarker analysis
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Mar 11, 2021
Breast Tumors Trial in San Francisco (Tamoxifen, Vorinostat, Pembrolizumab)
Terminated
- Breast Neoplasms
- Tamoxifen
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco Medical Center
Jun 22, 2020
NSCLC Trial in Worldwide (nab-paclitaxel IV, CC-486, Duravalumab)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- nab-paclitaxel IV
- +2 more
-
San Francisco, California
- +33 more
Jan 24, 2022
Hepatocellular Carcinoma Developed After Direct Acting Antiviral
Unknown status
- Hepatocellular Carcinoma
- DNA methylation
- (no location specified)
Jan 12, 2020
Gestational Diabetes Trial in Saint Petersburg (Life-style modification, insulin therapy if needed)
Unknown status
- Gestational Diabetes Mellitus
- Life-style modification, insulin therapy if needed
-
Saint Petersburg, Russian FederationAlmazov NMRC
Feb 11, 2020
Schizophrenia Trial in Barcelona (Cognitive Remediation Therapy)
Unknown status
- Schizophrenia
- Cognitive Remediation Therapy
-
Barcelona, SpainHospital Clinic de Barcelona
Feb 18, 2020
Breast Cancer, Obesity, Weight Change, Body Trial (Very low calorie ketogenic diet (VLCKD), Group educational intervention
Not yet recruiting
- Breast Cancer
- +3 more
- Very low calorie ketogenic diet (VLCKD)
- Group educational intervention program (IGOBE)
- (no location specified)
Sep 19, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (Venetoclax, Azacitadine, Vorinostat)
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Venetoclax
- +5 more
- (no location specified)
Apr 11, 2022
Neurobiology of Posttraumatic Stress Disorder Dysfunction and
Enrolling by invitation
- Posttraumatic Stress Disorder
-
Belmont, MassachusettsMcLean Hospital
Sep 14, 2022
Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))
Completed
- Acute Myelogenous Leukemia
- Decitabine
- +4 more
-
Los Angeles, California
- +32 more
Jun 22, 2022
Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)
Recruiting
- Hormone Receptor Positive Breast Carcinoma
- +6 more
- Liquid biopsy and CT scan
-
Bergame, Bergamo, Italy
- +6 more
Apr 13, 2023
Epigenetics of TNBC in Overweight and Obese Hispanic &
Withdrawn
- Triple Negative Breast Cancer
- Needle core biopsy
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 15, 2022
Healthy Aging, Age-Related Sarcopenia, Testosterone Deficiency Trial (Saline, Testosterone Undecanoate)
Not yet recruiting
- Healthy Aging
- +2 more
- Saline
- Testosterone Undecanoate
- (no location specified)
Jul 19, 2023
Psoriasis, Aging, Epigenetic Disorder Trial in Providence (TILDRAKIZUMAB)
Recruiting
- Psoriasis
- +3 more
- TILDRAKIZUMAB
-
Providence, Rhode IslandClinical Trials Center for Skin Diseases: Rhode Island Hospital,
Apr 9, 2022
Chronic Rhinosinusitis With Nasal Polyps Trial (Mepolizumab 100 MG Injection)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Mepolizumab 100 MG Injection
- (no location specified)
Jun 16, 2023
Premature Birth Trial in Milan (Early Intervention)
Active, not recruiting
- Premature Birth
- Early Intervention
-
Milan, ItalyNICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Feb 2, 2023